Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 15 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Companion diagnostic tests
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
See all tags

Swiss List of Analyses updated in January 2026

On December 3, 2025, the Swiss Federal Office of Public Health announced amendments to the Healthcare Benefit Ordinance, including its Annex 3 (the List of Analysis). The modifications include the adjustment of indications for the occult blood test for early detection of colon cancer (alignment with Art. 12e KLV), tariff updates (e.g., tariff reduction for Procalcitonin test), and regulatory amendments to existing codes.

One new code, 3489.00 "Dermatophytes" (nucleic acid amplification), is introduced with a tariff of 119.70 CHF.

The amendments entered into force on January 1, 2026.

See the details in German here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.

Tags
Switzerland
Reimbursement
In-vitro diagnostic tests

The latest related news

05
Jan 2026

First device obtained regular reimbursement after the pre-LPPR scheme in France

On December 19, 2025, an order was issued registering the Symplicity Spyral renal denervation catheter in Title V of the List of Reimbursable Products and Services (LPPR), enabling add-on reimbursement for medical devices used in hospital settings. The Symplicity Spyral received a positive opinion for LPPR registration in December 2023, following transitional coverage under the French innovative payment scheme known as pre-LPPR since December 2022.
Read more
31
Dec 2025

Implantable cardiac defibrillation devices added to the Belgian List of implants and invasive devices

On December 5, 2025, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the List of implants and invasive medical devices effective January 1, 2026. A new section “Cardiac defibrillator” was added with 15 new material codes for single-chamber cardioverter defibrillators (ICD), dual-chamber ICDs, cardiac resynchronization therapy defibrillators (CRT-D), subcutaneous cardiac defibrillators, and electrodes. A new Nominative list was created with eligible branded devices in connection with new material codes for cardiac defibrillators.
Read more
26
Dec 2025

New classification systems for procedure and diagnosis coding will be implemented in 2027 in Italy

On December 10, 2025, the Ministry of Health published the Decree for the update of classification systems for diagnosis and procedure coding, effective in 2027, with updates scheduled at least every two years and the continued use of ICD-10-IM until the transition to ICD-11. Implementation will proceed through a pilot phase in 2025 and a nationwide rollout in 2026, supported by conversion tools from ICD-9-CM to ensure continuity, with ICD-9-CM entirely discontinued as of January 1, 2027.
Read more
23
Dec 2025

First reimbursement category for health apps announced in Switzerland

On December 3, 2025, the Swiss Federal Office of Public Health announced amendments to the List of Medical Aids (Annex 2 of the Healthcare Benefit Ordinance or MiGeL), which will take effect in 2026. From July 1, 2026, the MiGeL List will include a new chapter for digital health applications. The first generic category to be registered covers a health application for Cognitive Behavioral Therapy for depression.
Read more
22
Dec 2025

New CCAM codes introduced in France

In mid-December 2025, a new version of the Common Classification of Medical Procedures (CCAM v.81), effective January 1, 2026, was published. Multiple changes were implemented, including the introduction of four new procedure codes, the provisional registration of four codes, the deletion of a few codes, the modification of tariffs for numerous activities/phases, and the amendment of existing services.
Read more